MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study Save

Date Added
September 10th, 2019
PRO Number
Pro00088665
Researcher
Souvik Sen

List of Studies

Keywords
Stroke, Stroke Recovery
Summary

MultiStem is regenerative medicine derived from donated human cells to treat acute ischemic stroke within 36 hours after symptom onset. Stroke leads to brain cell injury and many stroke patients suffer functional deficits as results. The purpose of this study is to evaluate safety and effectiveness of MultiStem on functional outcome in subjects with ischemic stroke.

Institution
Palmetto
Recruitment Contact
Mihyun Lim
803-545-6078
Mihyun.Lim@uscmed.sc.edu

Change_preferences

-- OR --

Create_login